SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-19-009785
Filing Date
2019-05-30
Accepted
2019-05-30 12:05:39
Documents
1
Period of Report
2019-05-15

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT ownership.html 3  
1 OWNERSHIP DOCUMENT ownership.xml 3 2963
  Complete submission text file 0001213900-19-009785.txt   4660
Mailing Address 609-610 21ST CENTURY TOWER 40 LIANGMAQIAO ROAD, CHAOYANG DISTRICT BEIJING F4 100016
Business Address 609-610 21ST CENTURY TOWER 40 LIANGMAQIAO ROAD, CHAOYANG DISTRICT BEIJING F4 100016 9493506999
XYNOMIC PHARMACEUTICALS HOLDINGS, INC. (Issuer) CIK: 0001697805 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address SUITE 3306, K. WAH CENTRE 1010 MIDDLE HUAIHAI ROAD SHANGHAI F4 200031
Business Address
Wu Wentao Jason (Reporting) CIK: 0001774745 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38120 | Film No.: 19865428